Research Article
Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
Table 2
Clinical characteristics of the PSC patients with concurrent UC (
).
| | Gender, male : female | 17 : 18 | | Age at diagnosis of PSC, yrs | | | Age at diagnosis of colitis, yrs | | | Initial diagnosis: | | | PSC | 10 | | Colitis | 10 | | Both | 15 | | Symptoms, yes : no | 8 : 27 | | Site of inflammation: | | | Total colitis (right-sided) | 35 (30) | | Left-sided colitis | 0 | | Proctitis | 0 | | Distribution: | | | Patchy | 30 | | Diffuse | 5 | | Back wash ileitis: | | | Yes | 13 | | No | 16 | | Unknown | 6 | | Rectal sparing, yes : no | 18 : 17 | | Colitic cancer | 2 | | Liver biopsy Ludwig’s stage: | | | Stage I | 2 | | Stage II | 17 | | Stage III | 3 | | Stage IV | 1 | | Unknown | 12 | | Lichtiger Clinical Activity Index (CAI) | 4 (2-8) | | Endoscopic UC severity score | | | Mayo endoscopic score | 1 (1-3) | | Ulcerative Colitis Endoscopic Index of Severity (UCEIS) | 2 (1-5) | | Treatmenta: | | | Ursodeoxycholic acid | 31 | | 5-Aminosalicylic acid | 24 | | Prednisolone | 12 | | Granulocyte and monocyte adsorptive apheresis | 5 | | Azathioprine | 3 |
|
|
Data are the , median (min-max), or the number of patients. aSome patients had more than one treatment. |